These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2081565)

  • 1. [A comparative study of the antiheparin activity and acute toxicity of stellins].
    Grigorova LV; Rozkin MIa; Rybin VK; Efimov VS; Makarov NV
    Farmakol Toksikol; 1990; 53(6):31-3. PubMed ID: 2081565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiheparin properties of synthetic polycations].
    Dubovik VV; Etlis VS; Baluda VP; Sushkevich GN; Shevchuk AS
    Farmakol Toksikol; 1975; 38(2):193-8. PubMed ID: 1227887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiheparin and toxic properties of quaternary ammonium salts of the monodispersed oligomers of conidine].
    Efimov VS; Chernova OV; Berestetskaia TZ; Nekrasov AV
    Farmakol Toksikol; 1983; 46(4):57-61. PubMed ID: 6617837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The experimental effect of the copolymer of 1-vinyl-3-methyl imidazole iodide with maleic acid diethyl ester on blood coagulability].
    Afanas'eva GV; Antonovich AA; Efimov VS; Smirnov AI
    Farmakol Toksikol; 1991; 54(5):31-3. PubMed ID: 1800142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiheparin activity of polymers based on the alkaloid, lupinine].
    Usmanova DM; Musaev UN; Efimov VS
    Farmakol Toksikol; 1979; 42(6):628-32. PubMed ID: 499471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The blood coagulation system under overdoses of the copolymer of 1-vinyl-3-methylimidazole iodide with the diethyl ether of maleic acid demonstrating antiheparin activity].
    Afanas'eva GV; Smirnov AI; Efimov VS
    Eksp Klin Farmakol; 1993; 56(6):32-4. PubMed ID: 8111293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro antiheparin action of berberine on the dog and human blood.
    Sabir M; Bhide NK
    Indian J Physiol Pharmacol; 1971 Jul; 15(3):97-100. PubMed ID: 5137671
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
    Poon MC; Hurst RE; Rives MS
    Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interaction of the calcium salt of heparin with specific antagonists and ethacizine].
    Ushkalova EA; Petrov AD; Kremneva VF; Shcheglova NV
    Farmakol Toksikol; 1988; 51(6):53-6. PubMed ID: 3234542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiheparin activity of the aneurysm wall and parietal thrombus and blood plasma of patients with aortic aneurysm].
    Gacko M; Worowska A; Kowalewski R; Guzowski A; Lapiński R; Panek B
    Przegl Lek; 2006; 63(2):58-60. PubMed ID: 16967710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexoproductive and antiheparin properties of low density lipoproteins (LDL). V. Optimum conditions of the coagulation method to determine antiheparin activity in the blood plasma.
    Rółkowski R; Worowski K; Skrzydlewski Z
    Ann Med Univ Bialyst Pol; 1993; 38(1):51-5. PubMed ID: 7922485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.